Starpharma Holdings Limited

OTCPK:SPHR.F Stock Report

Market Cap: US$26.1m

Starpharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:SPHR.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Nov 24BuyUS$18,571Robert ThomasIndividual300,000US$0.062
23 Oct 24BuyUS$30,660Robert ThomasIndividual500,000US$0.061
13 Sep 24BuyUS$12,486Russell BasserIndividual200,000US$0.062
05 Sep 24SellUS$184,617Orbis Investment Management LimitedCompany2,850,561US$0.065
02 Sep 24BuyUS$27,002David McIntyreIndividual405,886US$0.067
02 Sep 24BuyUS$22,885Robert ThomasIndividual350,000US$0.065
23 Aug 24SellUS$265,042Orbis Investment Management LimitedCompany4,248,017US$0.062
15 Aug 24BuyUS$339,093Ingot Capital Management Pty Ltd. (Utilico)Company5,500,000US$0.069
31 Jul 24SellUS$296,576Orbis Investment Management LimitedCompany4,661,466US$0.064
28 Jun 24BuyUS$53,175Jeff DaviesIndividual879,687US$0.06
28 Jun 24SellUS$339,298Orbis Investment Management LimitedCompany5,639,737US$0.06
26 Jun 24BuyUS$11,834Robert ThomasIndividual200,000US$0.059
25 Jun 24BuyUS$6,605Lynda ChengIndividual110,555US$0.06
21 Jun 24SellUS$351,655Orbis Investment Management LimitedCompany5,351,615US$0.066
20 Jun 24BuyUS$4,493Robert ThomasIndividual250,000US$0.061
30 May 24BuyUS$9,347Cheryl MaleyIndividual125,000US$0.076
29 May 24BuyUS$11,752Robert ThomasIndividual150,000US$0.079
14 May 24SellUS$365,667Orbis Investment Management LimitedCompany4,229,661US$0.086
15 Apr 24BuyUS$8,401Robert ThomasIndividual100,000US$0.084
12 Apr 24BuyUS$6,473Russell BasserIndividual71,428US$0.091
10 Apr 24BuyUS$23,440Robert ThomasIndividual250,000US$0.095

Insider Trading Volume

Insider Buying: SPHR.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SPHR.F?
Owner TypeNumber of SharesOwnership Percentage
State or Government3,200,0000.765%
Private Companies16,466,1783.94%
Individual Insiders20,885,1475%
Institutions159,371,48738.1%
General Public218,184,22552.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 47.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.6%
Allianz Asset Management GmbH
48,480,000US$3.0m0%no data
7.91%
ICM Limited
33,066,682US$2.1m54.8%0.36%
4.98%
Orbis Investment Management Limited
20,839,919US$1.3m-36.1%no data
4.85%
Fidelity International Ltd
20,291,445US$1.3m0%no data
4.34%
M&G Investment Management Limited
18,156,714US$1.1m0%no data
2.8%
Ingot Capital Management Pty Ltd. (Utilico)
11,705,000US$730.6k96.6%52.75%
1.21%
T & N Argyrides Investments Pty. Ltd.
5,060,000US$315.8k0%no data
1.1%
Kingsley Bartholomew
4,612,025US$287.9k34.6%no data
1.04%
Lavya Pty Ltd
4,344,628US$271.2k0%no data
0.97%
Jacinth Fairley
4,055,434US$253.1k0%no data
0.94%
Peter Jackson
3,921,959US$244.8k49.7%no data
0.88%
E Equities Pty Ltd
3,700,000US$230.9k0%no data
0.84%
All-States Finances Pty. Limited, Asset Management Arm
3,500,000US$218.5k0%2.05%
0.8%
Applecross Secretarial Services Pty Ltd.
3,361,550US$209.8k0%no data
0.77%
The Industrial Development Authority Of St. Charles County, Missouri
3,200,000US$199.7k0%no data
0.73%
Robert Thomas
3,050,000US$190.4k35.6%no data
0.72%
Thomas Argyrou
3,000,000US$187.3k0%no data
0.6%
Norges Bank Investment Management
2,496,164US$155.8k0%no data
0.22%
Jeff Davies
929,687US$58.0k0%no data
0.2%
Australian Super Pty Ltd
821,563US$51.3k0%no data
0.1%
David McIntyre
422,126US$26.3k2,500%no data
0.068%
A. Eglezos
285,827US$17.8k0%no data
0.065%
Russell Basser
271,428US$16.9k280%no data
0.041%
Lynda Cheng
170,555US$10.6k0%no data
0.03%
Cheryl Maley
125,000US$7.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:56
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Starpharma Holdings Limited is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Tanushree JainBell Potter
Matthijs SmithCanaccord Genuity